monobutyryl cyclic amp has been researched along with alprostadil in 1 studies
Studies (monobutyryl cyclic amp) | Trials (monobutyryl cyclic amp) | Recent Studies (post-2010) (monobutyryl cyclic amp) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
---|---|---|---|---|---|
55 | 0 | 2 | 7,136 | 864 | 761 |
Protein | Taxonomy | monobutyryl cyclic amp (IC50) | alprostadil (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
al-Mokdad, M; Fujimaki, M; Hayakawa, Y; Hiraga, K; Niiya, K; Sakuragawa, N; Shinbo, M | 1 |
1 other study(ies) available for monobutyryl cyclic amp and alprostadil
Article | Year |
---|---|
Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8.
Topics: Alprostadil; Bucladesine; Culture Media, Conditioned; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Gene Expression Regulation; Humans; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1995 |